Pharma

Your Article Summary

See Latest Articles

Avigen Reports Third Quarter 2008 Financial Results
Avigen, 01/09/09

Avigen, Inc., a biopharmaceutical company innovating therapeutics for neurological care, reported financial results. Avigen had approximately $56 million in financial assets, including cash, cash equivalents, and available-for-sale securities and restricted investments, compared with approximately $78 million at December 31, 2007.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

CPSI Profits Down, Revenue Up
HealthDataManagement, 11/02/09

Antigenics Reports Third Quarter 2009 Financial Results
Antigenics, 11/05/09

See All of Financial Reports